• Complete Patient Assistance Program/ Reimbursement Assistance Program Management capabilities, including clinical support and drug fulfillment.
• Facilitate manufacturer-sponsored patient-focused disease education and management programming.
• Enroll eligible patients in manufacturer-supported indigent care programs.
• Operationalize manufacturer-sponsored clinical trials for patients enrolled under IRB-approved protocols.
• Adapt manufacturers' FDA-mandated RiskMAP guidelines for limited distribution drugs.
• Provide manufacturers with quaterly, monthly, or weekly prescriber-level utilization data for specific drugs.
• Automatic data reporting to IMS and NDC.
|
